-
1
-
-
45149118311
-
Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events
-
DOI 10.1038/nbt1407, PII NBT1407
-
M. Guerrini D. Beccati Z. Shriver A. Naggi K. Viswanathan. A. Bisio I. Capila J. C. Lansing S. Guglieri B. Fraser A. Al-Hakim N. S. Gunay Z. Zhang L. Robinson L. Buhse M. Nasr J. Woodcock R. Langer G. Venkataraman R. J. Linhardt B. Casu G. Torri R. Sasisekharan Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events Nat. Biotechnol. 2008 26 669 675 (Pubitemid 351824692)
-
(2008)
Nature Biotechnology
, vol.26
, Issue.6
, pp. 669-675
-
-
Guerrini, M.1
Beccati, D.2
Shriver, Z.3
Naggi, A.4
Viswanathan, K.5
Bisio, A.6
Capila, I.7
Lansing, J.C.8
Guglieri, S.9
Fraser, B.10
Al-Hakim, A.11
Gunay, N.S.12
Zhang, Z.13
Robinson, L.14
Buhse, L.15
Nasr, M.16
Woodcock, J.17
Langer, R.18
Venkataraman, G.19
Linhardt, R.J.20
Casu, B.21
Torri, G.22
Sasisekharan, R.23
more..
-
2
-
-
44849115945
-
Contaminated heparin associated with adverse clinical events and activation of the contact system
-
DOI 10.1056/NEJMoa0803200
-
T. K. Kishimoto K. Viswanathan T. Ganguly S. Elankumaran S. Smith K. Pelzer J. C. Lansing N. Sriranganathan G. Zhao Z. Galcheva-Gargova A. Al-Hakim G. S. Bailey B. Fraser S. Roy T. Rogers-Cotrone L. Buhse M. Whary J. Fox M. Nasr G. J. Dal Pan Z. Shriver R. S. Langer G. Venkataraman K. F. Austen J. Woodcock R. Sasisekharan Contaminated Heparin Associated with Adverse Clinical Events and Activation of the Contact System N. Engl. J. Med. 2008 358 2457 2467 (Pubitemid 351793019)
-
(2008)
New England Journal of Medicine
, vol.358
, Issue.23
, pp. 2457-2467
-
-
Kishimoto, T.K.1
Viswanathan, K.2
Ganguly, T.3
Elankumaran, S.4
Smith, S.5
Pelzer, K.6
Lansing, J.C.7
Sriranganathan, N.8
Zhao, G.9
Galcheva-Gargova, Z.10
Al-Hakim, A.11
Bailey, G.S.12
Fraser, B.13
Roy, S.14
Rogers-Cotrone, T.15
Buhse, L.16
Whary, M.17
Fox, J.18
Nasr, M.19
Dal Pan, G.J.20
Shriver, Z.21
Langer, R.S.22
Venkataraman, G.23
Austen, K.F.24
Woodcock, J.25
Sasisekharan, R.26
more..
-
4
-
-
58049216683
-
Outbreak of Adverse Reactions Associated with Contaminated Heparin
-
B. Blossom A. J. Kallen P. R. Patel A. Elward L. Robinson G. P. Gao R. Langer K. M. Perkins J. L. Jaeger K. M. Kurkjian M. Jones S. F. Schillie N. Shehab D. Ketterer G. Venkataraman T. K. Kishimoto Z. Shriver A. W. McMahon K. F. Austen S. Kozlowski A. Srinivasan G. Turabelidze C. V. Gould M. J. Arduino R. Sasisekharan Outbreak of Adverse Reactions Associated with Contaminated Heparin N. Engl. J. Med. 2008 359 2674 2684
-
(2008)
N. Engl. J. Med.
, vol.359
, pp. 2674-2684
-
-
Blossom, B.1
Kallen, A.J.2
Patel, P.R.3
Elward, A.4
Robinson, L.5
Gao, G.P.6
Langer, R.7
Perkins, K.M.8
Jaeger, J.L.9
Kurkjian, K.M.10
Jones, M.11
Schillie, S.F.12
Shehab, N.13
Ketterer, D.14
Venkataraman, G.15
Kishimoto, T.K.16
Shriver, Z.17
McMahon, A.W.18
Austen, K.F.19
Kozlowski, S.20
Srinivasan, A.21
Turabelidze, G.22
Gould, C.V.23
Arduino, M.J.24
Sasisekharan, R.25
more..
-
5
-
-
79956155600
-
-
FDA Drug Safety Communication: Update: Follow up to the Public Health Alert about Changes to the Heparin http://www.fda.gov/D rugs/DrugS afety Postm arketDrugSa fetyInforma tionforPatients and Providers/ucm207506.htm
-
FDA Drug Safety Communication: Update: Follow up to the Public Health Alert about Changes to the Heparin http://www.fda.gov/Drugs/DrugSafety PostmarketDrugSafetyInformationforPatientsandProviders/ucm207506.htm
-
-
-
-
6
-
-
79956157124
-
-
FDA's Ongoing Heparin Investigation http://www .fda.gov/New sEvents/Testi mony/ucm115 242.htm
-
FDA's Ongoing Heparin Investigation http://www.fda.gov/NewsEvents/ Testimony/ucm115242.htm
-
-
-
-
8
-
-
77749277014
-
Identification of Chemically Sulfated/desulfated Glycosaminoglycans in Contaminated Heparins and Development of a Simple Assay for the Detection of Most Contaminants in Heparin
-
J. Pan Y. Qian X. Zhou A. Pazandak S. B. Frazier P. Weiser H. Lu L. Zhang Identification of Chemically Sulfated/desulfated Glycosaminoglycans in Contaminated Heparins and Development of a Simple Assay for the Detection of Most Contaminants in Heparin Glycobiol. Insights 2010 1 12
-
(2010)
Glycobiol. Insights
, pp. 1-12
-
-
Pan, J.1
Qian, Y.2
Zhou, X.3
Pazandak, A.4
Frazier, S.B.5
Weiser, P.6
Lu, H.7
Zhang, L.8
-
9
-
-
79251584385
-
A New Approach for Heparin Standardization: Combination of Scanning UV Spectroscopy, Nuclear Magnetic Resonance and Principal Component Analysis
-
M. A. Lima T. R. Rudd E. H. C. de Farias L. F. Ebner T. F. Gesteira L. M. de Souza A. Mendes C. R. Córdula J. R. M. Martins D. Hoppensteadt J. Fareed G. L. Sassaki E. A. Yates I. L. S. Tersariol H. B. Nader A New Approach for Heparin Standardization: Combination of Scanning UV Spectroscopy, Nuclear Magnetic Resonance and Principal Component Analysis PLoS One 2011 6 1 e15970
-
(2011)
PLoS One
, vol.6
, Issue.1
, pp. 15970
-
-
Lima, M.A.1
Rudd, T.R.2
De Farias, E.H.C.3
Ebner, L.F.4
Gesteira, T.F.5
De Souza, L.M.6
Mendes, A.7
Córdula, C.R.8
Martins, J.R.M.9
Hoppensteadt, D.10
Fareed, J.11
Sassaki, G.L.12
Yates, E.A.13
Tersariol, I.L.S.14
Nader, H.B.15
-
11
-
-
70350133604
-
Orthogonal analytical approaches to detect potential contaminants in heparin
-
M. Guerrini Z. Zhang Z. Shriver A. Naggi S. Masuko R. Langer B. Casu R. J. Linhardt G. Torri R. Sasisekharan Orthogonal analytical approaches to detect potential contaminants in heparin Proc. Natl. Acad. Sci. U. S. A. 2009 106 16956 16961
-
(2009)
Proc. Natl. Acad. Sci. U. S. A.
, vol.106
, pp. 16956-16961
-
-
Guerrini, M.1
Zhang, Z.2
Shriver, Z.3
Naggi, A.4
Masuko, S.5
Langer, R.6
Casu, B.7
Linhardt, R.J.8
Torri, G.9
Sasisekharan, R.10
-
12
-
-
79952611734
-
Construction and use of a library of bona fide heparins employing 1H NMR and multivariate analysis
-
T. R. Rudd D. Gaudesi M. A. Skidmore M. Ferro M. Guerrini B. Mulloy G. Torri E. A. Yates Construction and use of a library of bona fide heparins employing 1H NMR and multivariate analysis Analyst 2011 136 1380
-
(2011)
Analyst
, vol.136
, pp. 1380
-
-
Rudd, T.R.1
Gaudesi, D.2
Skidmore, M.A.3
Ferro, M.4
Guerrini, M.5
Mulloy, B.6
Torri, G.7
Yates, E.A.8
-
13
-
-
79952603018
-
High-sensitivity visualisation of contaminants in heparin samples by spectral filtering of 1H NMR spectra
-
T. R. Rudd D. Gaudesi M. A. Lima M. A. Skidmore B. Mulloy G. Torri H. B. Nader M. Guerrini E. A. Yates High-sensitivity visualisation of contaminants in heparin samples by spectral filtering of 1H NMR spectra Analyst 2011 136 1390
-
(2011)
Analyst
, vol.136
, pp. 1390
-
-
Rudd, T.R.1
Gaudesi, D.2
Lima, M.A.3
Skidmore, M.A.4
Mulloy, B.5
Torri, G.6
Nader, H.B.7
Guerrini, M.8
Yates, E.A.9
-
14
-
-
79956139338
-
Heparin Sodium Stage 2 Monograph
-
Heparin Sodium Stage 2 Monograph. Pharmacopeial Forum 35, 2009
-
(2009)
Pharmacopeial Forum 35
-
-
-
18
-
-
57649201349
-
Glycosaminoglycan origin and structure revealed by multivariate analysis of NMR and CD spectra
-
T. R. Rudd M. A. Skidmore S. E. Guimond C. Cosentino G. Torri D. G. Fernig R. M. Lauder M. Guerrini E. A. Yates Glycosaminoglycan origin and structure revealed by multivariate analysis of NMR and CD spectra Glycobiology 2009 19 52 67
-
(2009)
Glycobiology
, vol.19
, pp. 52-67
-
-
Rudd, T.R.1
Skidmore, M.A.2
Guimond, S.E.3
Cosentino, C.4
Torri, G.5
Fernig, D.G.6
Lauder, R.M.7
Guerrini, M.8
Yates, E.A.9
-
19
-
-
0023255762
-
-
B. Casu A. Naggi P. Oreste G. Torri J. Pangrazzj A. Maggi M. Abbadini M. B. Donati Lancet 1987 329 1088
-
(1987)
Lancet
, vol.329
, pp. 1088
-
-
Casu, B.1
Naggi, A.2
Oreste, P.3
Torri, G.4
Pangrazzj, J.5
Maggi, A.6
Abbadini, M.7
Donati, M.B.8
-
20
-
-
69749122095
-
Isolation and characterization of contaminants in recalled unfractionated heparin and low-molecular-weight heparin
-
C. Viskov E. Bouley P. Hubert C. Martinez F. Herman W. Jeske D. Hoppensteadt J. M. Walenga J. Fareed Isolation and characterization of contaminants in recalled unfractionated heparin and low-molecular-weight heparin Clin. Appl. Thromb./Hemostasis 2009 15 395 401
-
(2009)
Clin. Appl. Thromb./Hemostasis
, vol.15
, pp. 395-401
-
-
Viskov, C.1
Bouley, E.2
Hubert, P.3
Martinez, C.4
Herman, F.5
Jeske, W.6
Hoppensteadt, D.7
Walenga, J.M.8
Fareed, J.9
-
21
-
-
79956061840
-
Toxicology and Therapeutic Drug Monitoring
-
P. Jatlow S. Gray Toxicology and Therapeutic Drug Monitoring Clinical Chemistry 1982 28 256
-
(1982)
Clinical Chemistry
, vol.28
, pp. 256
-
-
Jatlow, P.1
Gray, S.2
-
22
-
-
0028678054
-
Subchronic toxicity study of tributoxyethyl phosphate in Wistar rats
-
M. Saitoh T. Umemura Y. Kawasaki J. Momma Y. Matsushima M. Matsumoto N. Eshita K. Isama M. Kaniwa M. Tsuda Subchronic toxicity study of tributoxyethyl phosphate in Wistar rats Eisei Shikenjo Hokoku 1994 112 27 39
-
(1994)
Eisei Shikenjo Hokoku
, vol.112
, pp. 27-39
-
-
Saitoh, M.1
Umemura, T.2
Kawasaki, Y.3
Momma, J.4
Matsushima, Y.5
Matsumoto, M.6
Eshita, N.7
Isama, K.8
Kaniwa, M.9
Tsuda, M.10
-
23
-
-
79956084696
-
-
http://toxmap.nlm.nih.gov/toxmap/main/chemPage.jsp?chem=2-Butoxyethanol
-
-
-
-
24
-
-
12244305336
-
NTP NTP Toxicology and Carcinogenesis Studies 2-Butoxyethanol (CAS NO.111-76-2) in F344/N Rats and B6C3F1 Mice (Inhalation Studies)
-
NTP NTP Toxicology and Carcinogenesis Studies 2-Butoxyethanol (CAS NO.111-76-2) in F344/N Rats and B6C3F1 Mice (Inhalation Studies) Natl. Toxicol. Prog. Tech. Rep. Ser 2000 484 1 290
-
(2000)
Natl. Toxicol. Prog. Tech. Rep. ser
, vol.484
, pp. 1-290
-
-
-
25
-
-
33745794453
-
Mechanisms of 2-butoxyethanol-induced hemangiosarcomas
-
DOI 10.1093/toxsci/kfl007
-
S. M. Corthals L. M. Kamendulis J. E. Klaunig Mechanisms of 2-butoxyethanol-induced hemangiosarcomas Toxicol. Sci. 2006 92 378 386 (Pubitemid 44018954)
-
(2006)
Toxicological Sciences
, vol.92
, Issue.2
, pp. 378-386
-
-
Corthals, S.M.1
Kamendulis, L.M.2
Klaunig, J.E.3
-
26
-
-
77950021471
-
Kupffer cells participate in 2-butoxyethanol-induced liver hemangiosarcomas
-
L. M. Kamendulis S. M. Corthals J. E. Klaunig Kupffer cells participate in 2-butoxyethanol-induced liver hemangiosarcomas Toxicology 2010 270 131 136
-
(2010)
Toxicology
, vol.270
, pp. 131-136
-
-
Kamendulis, L.M.1
Corthals, S.M.2
Klaunig, J.E.3
|